These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 36531260)

  • 41. In vivo efficacy & resistance prevention of cefiderocol in combination with ceftazidime/avibactam, ampicillin/sulbactam or meropenem using human-simulated regimens versus Acinetobacter baumannii.
    Gill CM; Santini D; Takemura M; Longshaw C; Yamano Y; Echols R; Nicolau DP
    J Antimicrob Chemother; 2023 Apr; 78(4):983-990. PubMed ID: 36775993
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Ampicillin-sulbactam against Acinetobacter baumannii infections: pharmacokinetic/pharmacodynamic appraisal of current susceptibility breakpoints and dosing recommendations.
    Abouelhassan Y; Kuti JL; Nicolau DP; Abdelraouf K
    J Antimicrob Chemother; 2024 Sep; 79(9):2227-2236. PubMed ID: 39031073
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Risk factors and resistance patterns of invasive
    Ge YL; Shan QW; Qiu Y; Zhou SP; Cheng YB; Wang F; Yang JW; Wan CM; Zhu Y; Xu Y; Chen MX; Lin DJ; Zhu CH; Zeng M
    Zhonghua Er Ke Za Zhi; 2022 Aug; 60(8):762-768. PubMed ID: 35922185
    [No Abstract]   [Full Text] [Related]  

  • 44. [Do different interpretative methods used for evaluation of checkerboard synergy test affect the results?].
    Ozseven AG; Sesli Çetin E; Ozseven L
    Mikrobiyol Bul; 2012 Jul; 46(3):410-20. PubMed ID: 22951653
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Evaluating the antibacterial effect of meropenem-loaded chitosan/sodium tripolyphosphate (TPP) nanoparticles on Acinetobacter baumannii isolated from hospitalized patients.
    Amini MS; Baseri Salehi M; Bahador N
    BMC Infect Dis; 2024 Jun; 24(1):631. PubMed ID: 38914964
    [TBL] [Abstract][Full Text] [Related]  

  • 46. In Vitro Interactions of Antibiotic Combinations of Colistin, Tigecycline, and Doripenem Against Extensively Drug-Resistant and Multidrug-Resistant Acinetobacter baumannii.
    Park GC; Choi JA; Jang SJ; Jeong SH; Kim CM; Choi IS; Kang SH; Park G; Moon DS
    Ann Lab Med; 2016 Mar; 36(2):124-30. PubMed ID: 26709259
    [TBL] [Abstract][Full Text] [Related]  

  • 47. In vitro activity of doripenem in combination with various antimicrobials against multidrug-resistant Acinetobacter baumannii: possible options for the treatment of complicated infection.
    Principe L; Capone A; Mazzarelli A; D'Arezzo S; Bordi E; Di Caro A; Petrosillo N
    Microb Drug Resist; 2013 Oct; 19(5):407-14. PubMed ID: 23659601
    [TBL] [Abstract][Full Text] [Related]  

  • 48. High-Dose Ampicillin-Sulbactam Combinations Combat Polymyxin-Resistant Acinetobacter baumannii in a Hollow-Fiber Infection Model.
    Lenhard JR; Smith NM; Bulman ZP; Tao X; Thamlikitkul V; Shin BS; Nation RL; Li J; Bulitta JB; Tsuji BT
    Antimicrob Agents Chemother; 2017 Mar; 61(3):. PubMed ID: 28052852
    [No Abstract]   [Full Text] [Related]  

  • 49.
    Rodriguez CH; Brune A; Nastro M; Vay C; Famiglietti A
    J Med Microbiol; 2020 Jul; 69(7):928-931. PubMed ID: 32584214
    [No Abstract]   [Full Text] [Related]  

  • 50. Synergistic activities between carbapenems and other antimicrobial agents against Acinetobacter baumannii including multidrug-resistant and extensively drug-resistant isolates.
    Kiratisin P; Apisarnthanarak A; Kaewdaeng S
    Int J Antimicrob Agents; 2010 Sep; 36(3):243-6. PubMed ID: 20541913
    [TBL] [Abstract][Full Text] [Related]  

  • 51. In vitro and in vivo activity of meropenem and sulbactam against a multidrug-resistant Acinetobacter baumannii strain.
    Ko WC; Lee HC; Chiang SR; Yan JJ; Wu JJ; Lu CL; Chuang YC
    J Antimicrob Chemother; 2004 Feb; 53(2):393-5. PubMed ID: 14729739
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Dose Optimization of Colistin Combinations against Carbapenem-Resistant Acinetobacter baumannii from Patients with Hospital-Acquired Pneumonia in China by Using an
    Bian X; Liu X; Chen Y; Chen D; Li J; Zhang J
    Antimicrob Agents Chemother; 2019 Apr; 63(4):. PubMed ID: 30745385
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Evaluation of the efficacy of colistin/sulbactam combination on carbapenem-resistant Acinetobacter baumannii strains].
    Çetinkol Y; Telli M; Altunçekiç Yıldırım A; Çalgın MK
    Mikrobiyol Bul; 2016 Jul; 50(3):460-5. PubMed ID: 27525401
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Investigation of oxacillinase genes in nosocomial multidrug-resistant Acinetobacter baumannii isolates by multiplex PCR and evaluation of their clonal relationship with Rep-PCR].
    Sarı B; Baran I; Alaçam S; Mumcuoğlu İ; Kurşun Ş; Aksu N
    Mikrobiyol Bul; 2015 Apr; 49(2):249-58. PubMed ID: 26167825
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Analysis of virulence phenotypes and antibiotic resistance in clinical strains of Acinetobacter baumannii isolated in Nashville, Tennessee.
    Boone RL; Whitehead B; Avery TM; Lu J; Francis JD; Guevara MA; Moore RE; Chambers SA; Doster RS; Manning SD; Townsend SD; Dent L; Marshall D; Gaddy JA; Damo SM
    BMC Microbiol; 2021 Jan; 21(1):21. PubMed ID: 33422000
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Antibacterial activity of epigallocatechin-3-gallate (EGCG) and its synergism with β-lactam antibiotics sensitizing carbapenem-associated multidrug resistant clinical isolates of Acinetobacter baumannii.
    Lee S; Razqan GS; Kwon DH
    Phytomedicine; 2017 Jan; 24():49-55. PubMed ID: 28160861
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Evaluation of Colistin-Ampicillin/Sulbactam Combination Efficacy in Imipenem-Resistant Acinetobacter baumannii Strains].
    Cıkman A; Ceylan MR; Parlak M; Karahocagil MK; Berktaş M
    Mikrobiyol Bul; 2013 Jan; 47(1):147-51. PubMed ID: 23390912
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Antimicrobial susceptibility and molecular characterization of multidrug-resistant Acinetobacter baumannii isolated in an university hospital].
    Direkel Ş; Çopur Çiçek A; Karagöz A; Aydoğan Ejder N; Oktay E; Delialioğlu N; Özgümüş OB; Durmaz R
    Mikrobiyol Bul; 2016 Oct; 50(4):522-534. PubMed ID: 28124957
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Distribution of blaOXA genes in Acinetobacter baumannii strains: a multicenter study].
    Ciftci IH; Aşık G; Karakeçe E; Oksüz L; Yağcı S; Sesli Çetin E; Ozdemir M; Atasoy AR; Koçoğlu E; Gül M; Kurtoğlu MG; Köksal Çakırlar F; Seyrek A; Berktaş M; Gültepe B; Ayyildiz A
    Mikrobiyol Bul; 2013 Oct; 47(4):592-602. PubMed ID: 24237428
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Using machine learning to optimize antibiotic combinations: dosing strategies for meropenem and polymyxin B against carbapenem-resistant Acinetobacter baumannii.
    Smith NM; Lenhard JR; Boissonneault KR; Landersdorfer CB; Bulitta JB; Holden PN; Forrest A; Nation RL; Li J; Tsuji BT
    Clin Microbiol Infect; 2020 Sep; 26(9):1207-1213. PubMed ID: 32061797
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.